Telesis Bio (Convertible Preferred Stock)

Funding Details
Awarder
Inbox
Date Award
May 18, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$21,000,000

Company Info
Company Description
Telesis Bio is a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries. The company empowers scientists to create novel, synthetic biology-enabled solutions for many of humanity's greatest challenges.
Market
Synthetic Biology
Location
San Diego, CA, USA
Coinvestors
Novalis LifeSciences, Northpond Ventures

Links